Clinical Trial Update: Evaluation of the Initial Safety and Efficacy of Keloid Lesions Treated With MF-4181 [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of MF-4181 for treating keloid lesions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keloid

Drugs mentioned

• MF-4181

Snippet

Sponsor: Halscion, Inc. | Conditions: Keloid | Phase 2 | Status: COMPLETED